Clinical Trial Update: A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating valacyclovir hydrochloride to prevent life-threatening cytomegalovirus disease in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• HIV Infection

Drugs mentioned

• Valacyclovir hydrochloride (valacyclovir hydrochloride)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infections, HIV Infections | Phase 3 | Status: COMPLETED